Results
Par Drugs Q2 FY27 Net Profit Falls 36% YoY
Board approved unaudited standalone financial results for Q2 and H1 FY27, reporting a net profit of ₹262.80 lakhs for the quarter.
Q2 revenue declined 4.3% YoY to ₹2,743.19 lakhs, while H1 revenue gre
